MicroRNA–mRNA Pairs Associated with Outcome in AML: From In Vitro Cell-Based Studies to AML Patients

Cytarabine is the primary chemotherapeutic agent used for treatment of acute myeloid leukemia (AML). Disease relapse after initial remission remains one of the most pressing therapeutic challenges in the treatment of AML. Relapsed disease is often resistant to cytarabine and subsequent salvage thera...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Pharmacol
Main Authors: Bhise, Neha S., Chauhan, Lata, Shin, Miyoung, Cao, Xueyuan, Pounds, Stanley, Lamba, Vishal, Lamba, Jatinder K.
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2016
Teme:
Pharmacology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4729948/
https://ncbi.nlm.nih.gov/pubmed/26858643
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2015.00324
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki